Aprea Therapeutics, Inc. (APRE)
0.8174
-0.02
(-2.19%)
USD |
NASDAQ |
Sep 02, 16:00
0.8196
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Cash from Operations (TTM) : -12.30M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.30M |
| March 31, 2026 | -12.57M |
| December 31, 2025 | -13.44M |
| September 30, 2025 | -13.55M |
| June 30, 2025 | -12.91M |
| March 31, 2025 | -12.97M |
| December 31, 2024 | -13.27M |
| September 30, 2024 | -13.97M |
| June 30, 2024 | -13.43M |
| March 31, 2024 | -13.08M |
| December 31, 2023 | -12.12M |
| September 30, 2023 | -12.29M |
| Date | Value |
|---|---|
| June 30, 2023 | -15.74M |
| March 31, 2023 | -21.08M |
| December 31, 2022 | -23.60M |
| September 30, 2022 | -29.10M |
| June 30, 2022 | -31.27M |
| March 31, 2022 | -30.48M |
| December 31, 2021 | -36.51M |
| September 30, 2021 | -41.30M |
| June 30, 2021 | -46.76M |
| March 31, 2021 | -48.66M |
| December 31, 2020 | -44.68M |
| September 30, 2020 | -40.77M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Zymeworks, Inc. | -119.20M |
| Rhythm Pharmaceuticals, Inc. | -105.35M |
| Onconetix, Inc. | -10.31M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |